Ottawa, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The global viral vectors and plasmid DNA manufacturing market size surpassed USD 6.26 billion in 2024 and is estimated to grow from USD 7.26 billion in 2025 ...

Chicago, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The global viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is expected to reach US$ 20.30 billion by 2033, ...

The "Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030" report has been added to ResearchAndMarkets.com's offering. The Viral Vectors and Plasmid DNA Manufacturing Market ...

DUBLIN, Jan. 12, 2021 /PRNewswire/ -- The "Viral Vectors & Plasmid DNA Global Market Report 2020-30: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering. Viral ...

DUBLIN--(BUSINESS WIRE)--The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Overall world revenue for the viral vectors ...

Cell and gene therapies are redefining the treatments of rare diseases and cancers. Two CAR-T therapies, for instance, rapidly achieved FDA approval in the US and have emerged recently as the new ...

Methods for elucidating connectivity across the whole brain at the level of resolution of specific cell types or single neurons can add considerably to our understanding of neural circuits. Such ...

The global viral vectors and plasmid DNA manufacturing market was valued at $918.37 million in 2019, and is estimated to reach at $4,978.54 million by 2027, registering a CAGR of 24.9% from 2020 to ...

DUBLIN--(BUSINESS WIRE)--The "Global Viral Vectors & Plasmid DNA Market 2020-2030: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering. The global viral ...

(MENAFN- GlobeNewsWire - Nasdaq) The global viral vectors and plasmid DNA manufacturing market size is expected to be worth USD 26.66 billion by 2034 increasing from USD 7.26 billion in 2025 and is ...